remission
Showing 1 - 25 of >10,000
Remission of Acute Charcot-Neuroarthropathy of Foot.
Recruiting
- Acute Charcot Neuroarthropathy
- Total conatact cast
-
Chandigarh, IndiaPGIMER
Aug 23, 2023
Irritable Bowel Syndrome-like Symptoms, Crohn Disease Remission Trial (BK003, Placebo)
Not yet recruiting
- Irritable Bowel Syndrome-like Symptoms
- Crohn Disease Remission
- BK003
- Placebo
- (no location specified)
Oct 23, 2023
IBD Trial (Mediterranean diet and Anti-inflammatory diet)
Not yet recruiting
- Inflammatory Bowel Diseases
- Mediterranean diet and Anti-inflammatory diet
- (no location specified)
Jun 18, 2023
Dissecting Cellular and Molecular Atlas of Rheumatoid Arthritis
Recruiting
- Rheumatoid Arthritis
- Tapering and/or discontinuation of treatment based on AI-guidance
- +3 more
-
Rome, Italy
- +3 more
Jul 20, 2023
Giant Cell Arteritis Trial in Bonn (Methotrexate, Sodium chloride)
Recruiting
- Giant Cell Arteritis
- Methotrexate
- Sodium chloride
-
Bonn, GermanyMedical Clinic and Polyclinic III Internal medicine Oncology, He
Dec 16, 2022
Ulcerative Colitis, Histology Remission, Fecal Calprotetin Trial in Jinan (FIT + FC)
Recruiting
- Ulcerative Colitis
- +4 more
- FIT + FC
-
Jinan, Shandong, ChinaQilu hospital of Shandong University
Nov 14, 2022
Development of Minimally Invasive Methodology for Diabetyping to
Not yet recruiting
- Type 2 Diabetes
- (no location specified)
Nov 3, 2023
IBD Trial in Roma (Multimodal ultrasound)
Recruiting
- Inflammatory Bowel Diseases
- Multimodal ultrasound
-
Roma, ItalyFondazione Policlinico Gemelli IRCCS
Aug 3, 2023
Type 2 Diabetes Trial (Dietary intervention)
Not yet recruiting
- Type 2 Diabetes
- Dietary intervention
- (no location specified)
Jan 25, 2023
Rectal Cancer Trial in Taipei (Surgery)
Recruiting
- Rectal Cancer
- Surgery
-
Taipei, TaiwanJin-Tung LIANG
Jul 27, 2023
Diabetic Foot Trial in Madrid (2 weeks revision)
Not yet recruiting
- Diabetic Foot
- 2 weeks revision
-
Madrid, SpainClínica Universitaria de Podología de la Universidad Complutense
Nov 15, 2023
Graves' Disease Trial (Mycophenolate Mofetil, Oral, 250 Mg, methimazole, oral, 10mg)
Not yet recruiting
- Graves' Disease
- Mycophenolate Mofetil, Oral, 250 Mg
- methimazole, oral, 10mg
- (no location specified)
Sep 28, 2023
Myeloid Malignancies Trial in Chendu (fractionated busulfan-based conditioning regimen)
Recruiting
- Myeloid Malignancies
- fractionated busulfan-based conditioning regimen
-
Chendu, Sichuan, ChinaWest China Hospital, Sichuan University
Mar 29, 2023
ANCA-associated Vasculitis, Maintenance Therapy Trial in Beijing (Azathioprine, Telitacicept)
Recruiting
- ANCA-associated Vasculitis
- Maintenance Therapy
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 20, 2023
Type 2 Diabetes, Obesity, Morbid Trial (Calorie restriction via total food replacement)
Not yet recruiting
- Type 2 Diabetes
- Obesity, Morbid
- Calorie restriction via total food replacement
- (no location specified)
Mar 2, 2023
Severe Alcoholic Hepatitis Trial in New Delhi (Prednisolone, Standard Medical therapy, Placebo)
Not yet recruiting
- Severe Alcoholic Hepatitis
- Prednisolone
- +2 more
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences (ILBS)
Dec 2, 2023
3TR Systemic Lupus Erythematosus Study Protocol 2
Not yet recruiting
- Systemic Lupus Erythematosus (SLE)
- Blood sample
- +4 more
- (no location specified)
Feb 17, 2023
Remission WithVery Low-calorie Ketogenic Diet and Lifestyle
Recruiting
- Type 2 Diabetes Mellitus
- Overweight and Obesity
- VLCKD
-
Lausanne, SwitzerlandDr. Daniela Sofra
Aug 2, 2023
Microscopic Colitis Trial (Budesonide MMX®, Budesonide controlled ileal release (CR) capsules)
Not yet recruiting
- Microscopic Colitis
- Budesonide MMX®
- Budesonide controlled ileal release (CR) capsules
- (no location specified)
Jun 13, 2023
Treatment Free Remission (TFR) in CML Patients (CML-CP)Study
Not yet recruiting
- Chronic Myeloid Leukemia
- Treatment-free Remission
- TFR(Treatment-Free Remission)
- (no location specified)
Jun 27, 2022
Lupus or SLE, Nephritis Trial in Assiut (Baricitinib 4 MG, Baricitinib 2 MG, MMF)
Recruiting
- Lupus or SLE
- Nephritis
- Baricitinib 4 MG
- +2 more
-
Assiut, Yes, EgyptManal Hassanien
Jan 13, 2023
Obesity, Diabetes, Type 2 Trial in Loma Linda (Meal replacement system, Intensive lifestyle Intervention)
Recruiting
- Obesity
- Diabetes Mellitus, Type 2
- Meal replacement system
- Intensive lifestyle Intervention
-
Loma Linda, CaliforniaLoma Linda University Health
Jun 28, 2022